Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 06 05 2021
accepted: 14 07 2021
entrez: 11 8 2021
pubmed: 12 8 2021
medline: 24 8 2021
Statut: epublish

Résumé

To achieve herd immunity against COVID-19, it is crucial to know the drivers of vaccination intention and, thereby, vaccination. As the determinants of vaccination differ across vaccines, target groups and contexts, we investigate COVID-19 vaccination intention using data from university students from three countries, the Netherlands, Belgium and Portugal. We investigate the psychological drivers of vaccination intention using the 5C model as mediator. This model includes five antecedents of vaccination: Confidence, Complacency, Constraints, Calculation and Collective Responsibility. First, we show that the majority of students have a positive propensity toward getting vaccinated against COVID-19, though only 41% of students are completely acceptant. Second, using the 5C model, we show that 'Confidence' (β = 0.33, SE = 03, p < .001) and 'Collective Responsibility' (β = 0.35, SE = 04, p < .001) are most strongly related to students' COVID-19 vaccination intention. Using mediation analyses, we show that the perceived risk and effectiveness of the vaccine as well as trust in the government and health authorities indirectly relate to vaccination intention through 'Confidence'. The perceived risk of COVID-19 for one's social circle and altruism, the need to belong and psychopathy traits indirectly relate to vaccination intention through 'Collective Responsibility'. Hence, targeting the psychological characteristics associated with 'Confidence' and 'Collective Responsibility' can improve the effectiveness of vaccination campaigns among students.

Identifiants

pubmed: 34379648
doi: 10.1371/journal.pone.0255382
pii: PONE-D-21-15022
pmc: PMC8357093
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0255382

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Assessment. 2018 Jul;25(5):543-556
pubmed: 27411678
Psychol Assess. 2013 Mar;25(1):216-26
pubmed: 23148649
Vaccines (Basel). 2021 Jan 20;9(2):
pubmed: 33498282
Ann Behav Med. 2012 Oct;44(2):171-80
pubmed: 22547155
Vaccine. 2020 Jul 14;38(33):5131-5138
pubmed: 32409135
Exp Clin Psychopharmacol. 2014 Jun;22(3):222-8
pubmed: 24708144
Assessment. 2014 Feb;21(1):28-41
pubmed: 24322012
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Behav Res Methods. 2009 May;41(2):425-38
pubmed: 19363183
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Pers Assess. 2008 Mar;90(2):142-51
pubmed: 18444108
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Hum Vaccin Immunother. 2017 Nov 2;13(11):2503-2511
pubmed: 28949819
Vaccine. 2014 Nov 20;32(49):6649-54
pubmed: 25280436
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
BMJ. 2020 Jul 14;370:m2815
pubmed: 32665317
Drug Alcohol Depend. 2008 May 1;95(1-2):169-72
pubmed: 18243583
J Pers Soc Psychol. 1994 Dec;67(6):1063-78
pubmed: 7815302
Psychol Health. 2019 Mar;34(3):271-288
pubmed: 30406692
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Lancet. 2020 Nov 21;396(10263):1614-1616
pubmed: 33159850
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
J Consult Psychol. 1960 Aug;24:349-54
pubmed: 13813058
Immunity. 2020 May 19;52(5):737-741
pubmed: 32433946
PLoS One. 2014 Jan 24;9(1):e87164
pubmed: 24475246
Annu Rev Psychol. 2012;63:539-69
pubmed: 21838546
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Pers Soc Psychol Rev. 2011 Feb;15(1):28-50
pubmed: 20435807
Can J Psychiatry. 2000 Mar;45(2):156-65
pubmed: 10742875
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
Psychol Bull. 1995 May;117(3):497-529
pubmed: 7777651
Psychol Sci. 2013 Oct;24(10):1918-27
pubmed: 23955356
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Psychol Methods. 2002 Dec;7(4):422-45
pubmed: 12530702
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Lancet Infect Dis. 2021 May;21(5):e110
pubmed: 32941786
Psychol Belg. 2020 Jul 22;60(1):217-235
pubmed: 32742708

Auteurs

Annelot Wismans (A)

Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, The Netherlands.
The Erasmus University Rotterdam Institute for Behavior and Biology (EURIBEB), Rotterdam, The Netherlands.

Roy Thurik (R)

Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, The Netherlands.
The Erasmus University Rotterdam Institute for Behavior and Biology (EURIBEB), Rotterdam, The Netherlands.
Montpellier Business School, Montpellier, France.

Rui Baptista (R)

CEG-IST, Instituto Superior Técnico, University of Lisbon, Lisboa, Portugal.

Marcus Dejardin (M)

Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Université de Namur, Namur, Belgium.

Frank Janssen (F)

Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

Ingmar Franken (I)

The Erasmus University Rotterdam Institute for Behavior and Biology (EURIBEB), Rotterdam, The Netherlands.
Erasmus School of Social and Behavioural Sciences, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH